Pick Unichem Labs, look at Dishman Pharma: Prakash Diwan

Prakash Diwan of prakashdiwan.in told CNBC-TV18, "The midcap space is where the pharmaceuticals have kind of got ignored because the limelight has been taken away by the biggies. However, look at two companies which have also kind of getting into that rerating. One is Unichem Laboratories, it is a brilliant franchise, the way they have expanded, spent a lot of money in terms of building up strengths across distribution networks, that has started paying off very well. My sense is that there is a huge scale up that you would see in this company’s business going forward." "Dishman Pharmaceuticals & Chemicals always had issues with its products not getting into the right space but that has also changed because they completely rejiged the product mix. I am very bullish on Unichem. Dishman could take time, people would take time to buy into it as well but Unichem is definitely ripe for the picking amongst the midcap pharmaceuticals especially on the rerating angle," he said.